Page 16 - 《中国药房》2025年7期
P. 16

[17]  赵连友,孙英贤,李玉明,等 . 高血压合并动脉粥样硬化                        14(10):1237-1245.
               防治中国专家共识[J]. 中华高血压杂志,2020,28(2):               [28]  CHOPRA H K,WANDER G S,PONDE C K,et al. The
               116-123.                                            promise of cilnidipine in hypertension with comorbidities:
          [18]  袁洪,孙宁玲 . 口服抗高血压药物临床试验的有效性评                         national  consensus  statement:national  consensus  group
               价中国专家共识[J]. 中华高血压杂志,2015,23(4):                     comprises  cardiologists,nephrologists,and  diabetologists
               316-325.                                            from India in a national meet at new Delhi held on 22nd
          [19]  WU J R,LIOU S F,LIN S W,et al. Lercanidipine inhibits   May  2022[J].  J  Assoc  Physicians  India,2024,72(1):
               vascular  smooth  muscle  cell  proliferation  and  neointimal   88-95.
               formation  via  reducing  intracellular  reactive  oxygen  spe‐  [29]  HAJDYS  J,FULARSKI  P,LESZTO  K,et  al.  New  in‐
               cies  and  inactivating  Ras-ERK1/2  signaling  [J].  Pharma‐  sights into the nephroprotective potential of lercanidipine
               col Res,2009,59(1):48-56.                           [J]. Int J Mol Sci,2023,24(18):14048.
          [20]  ZANCHETTI  A,GENE  BOND  M,HENNIG  M,et  al.   [30]  张涛,王小茅,范群雄,等. 氨氯地平和非洛地平治疗中
               Calcium antagonist lacidipine slows down progression of   国人高血压的疗效与安全性的 Meta 分析[J]. 实用心脑
               asymptomatic  carotid  atherosclerosis:principal  results  of   肺血管病杂志,2013,21(3):37-40.
               the  European  Lacidipine  Study  on  Atherosclerosis   [31]  HUANG Q F,SHENG C S,LI Y,et al. A randomized con‐
              (ELSA),a  randomized,double-blind,long-term  trial[J].   trolled trial on the blood pressure-lowering effect of amlo‐
               Circulation,2002,106(19):2422-2427.                 dipine and nifedipine-GITS in sustained hypertension[J]. J
          [21]  SIMON A,GARIÉPY J,MOYSE D,et al. Differential ef‐  Clin Hypertens (Greenwich),2019,21(5):648-657.
               fects of nifedipine and co-amilozide on the progression of   [32]  CHAKRABORTY  R  N,LANGADE  D,MORE  S,et  al.
               early carotid wall changes[J]. Circulation,2001,103(24):  Efficacy  of  cilnidipine  (L/N-type  calcium  channel
               2949-2954.                                          blocker) in treatment of hypertension:a meta-analysis of
          [22]  PITT B,BYINGTON R P,FURBERG C D,et al. Effect      randomized  and  non-randomized  controlled  trials[J].  Cu‐
               of  amlodipine  on  the  progression  of  atherosclerosis  and   reus,2021,13(11):e19822.
               the occurrence of clinical events. PREVENT investigators  [33]  张慧敏,黄建凤,吴海英,等. 马来酸左旋氨氯地平与苯
               [J]. Circulation,2000,102(13):1503-1510.            磺酸氨氯地平治疗轻中度原发性高血压[J]. 中华高血压
          [23]  MA W,ZHAO L Y,HUA Q,et al. A18046 levamlodipine    杂志,2010,18(7):648-652.
               maleate or amlodipine besylate for treatment of hyperten‐  [34]  ONWUBERE B J,OBODO J O,OKE D A,et al. A ran‐
               sion[J]. J Hypertens,2018,36:e255.                  domised trial to compare the efficacy and safety of Felo‐
          [24]  DAHLÖF B,SEVER P S,POULTER N R,et al. Preven‐      dipine (Plendil)  and  Nifedipine (Adalat)  retard  in  pa‐
               tion  of  cardiovascular  events  with  an  antihypertensive   tients  with  mild-to-moderate  hypertension[J].  West Afr  J
               regimen of amlodipine adding perindopril as required ver‐  Med,2001,20(4):196-202.
               sus  atenolol  adding  bendroflumethiazide  as  required,in   [35]  MAKAROUNAS-KIRCHMANN   K, GLOVER-
               the  Anglo-Scandinavian  Cardiac  Outcomes  Trial-Blood   KOUDOUNAS  S,FERRARI  P.  Results  of  a  meta-
               Pressure  Lowering Arm (ASCOT-BPLA):a  multicentre   analysis  comparing  the  tolerability  of  lercanidipine  and
               randomised controlled trial[J]. Lancet,2005,366(9489):  other  dihydropyridine  calcium  channel  blockers[J].  Clin
               895-906.                                            Ther,2009,31(8):1652-1663.
          [25]  LIU  L  S,ZHANG Y  Q,LIU  G  Z,et  al. The  felodipine   [36]  霍勇,张慧敏,葛均波,等. 拉西地平与苯磺酸氨氯地平
               event reduction (FEVER) study:a randomized long-term   治疗中老年轻中度原发性高血压的对比分析[J]. 中国新
               placebo-controlled  trial  in  Chinese  hypertensive  patients  药杂志,2019,28(8):967-972.
               [J]. J Hypertens,2005,23(12):2157-2172.        [37]  UENG K C,SUN N L,EL MAKSOD A,et al. Efficacy
          [26]  LIU L,WANG J G,GONG L,et al. Comparison of active   and  tolerability  of  long-acting  nifedipine  GITS/OROS
               treatment and placebo in older Chinese patients with iso‐  monotherapy  or  combination  therapy  in  hypertensive  pa‐
               lated  systolic  hypertension.  Systolic  Hypertension  in   tients:results of a 12-week international,prospective,mul‐
               China (Syst-China) Collaborative Group[J]. J Hypertens,  ticentre,observational study[J]. Clin Drug Investig,2011,
               1998,16(12 Pt 1):1823-1829.                         31(9):631-642.
          [27]  GONG  L,ZHANG  W,ZHU  Y,et  al.  Shanghai  trial  of        (收稿日期:2024-11-07  修回日期:2025-03-03)
               nifedipine in the elderly(STONE)[J]. J Hypertens,1996,                             (编辑:林 静)





          · 778 ·    China Pharmacy  2025 Vol. 36  No. 7                               中国药房  2025年第36卷第7期
   11   12   13   14   15   16   17   18   19   20   21